|
|
|
Insider
Information: |
Ho Carole |
Relationship: |
Chief Medical Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
143,605 |
|
Indirect Shares
|
208,219 |
|
|
Direct
Value |
$2,961,135 |
|
|
Indirect Value
|
$4,293,476 |
|
|
Total
Shares |
351,824 |
|
|
Total
Value |
$7,254,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
11
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-02-09 |
4 |
S |
$37.10 |
$52,791 |
I/I |
(1,423) |
166,112 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-02-11 |
4 |
S |
$34.71 |
$101,284 |
I/I |
(2,918) |
170,663 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
173,087 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2023-01-04 |
4 |
S |
$28.69 |
$83,574 |
I/I |
(2,913) |
175,500 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2023-02-08 |
4 |
S |
$30.88 |
$46,968 |
I/I |
(1,521) |
180,183 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2023-08-10 |
4 |
S |
$24.15 |
$68,997 |
I/I |
(2,857) |
185,577 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2023-08-21 |
4 |
S |
$22.60 |
$56,003 |
I/I |
(2,478) |
185,331 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
108 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|